Autosomal dominant hypocalcaemia due to a novel CASR mutation: clinical and genetic implications

Lucia Gagliardi; Morton G. Burt; Jinghua Feng; Nicola K. Poplawski; Hamish S. Scott

doi:10.1111/cen.13104

Autosomal dominant hypocalcaemia due to a novel CASR mutation: clinical and genetic implications

Lucia Gagliardi, Morton G. Burt, Jinghua Feng, Nicola K. Poplawski, Hamish S. Scott

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Abstract

We report a patient from a family with autosomal dominant hypocalcaemia who also had prednisolone‐treated Langerhans’ cell histiocytosis and familial genetic studies identifying a novel calcium‐sensing receptor (CASR ) mutation. We describe an approach to define pathogenicity of a genetic variation of uncertain significance and postulate that bisphosphonates may have paradoxically increased fracture risk in our patient.

Original language	English
Pages (from-to)	495-497
Number of pages	3
Journal	Clinical Endocrinology
Volume	85
Issue number	3
DOIs	https://doi.org/10.1111/cen.13104
Publication status	Published - Sept 2016

Keywords

genetic implications
clinical implications
clinical and genetic implications
Autosomal dominant hypocalcaemia
novel CASR mutation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/cen.13104Licence: In Copyright

Cite this

@article{76342fb908bf4f5e8a5370b2de1794fe,

title = "Autosomal dominant hypocalcaemia due to a novel CASR mutation: clinical and genetic implications",

abstract = "We report a patient from a family with autosomal dominant hypocalcaemia who also had prednisolone‐treated Langerhans{\textquoteright} cell histiocytosis and familial genetic studies identifying a novel calcium‐sensing receptor (CASR ) mutation. We describe an approach to define pathogenicity of a genetic variation of uncertain significance and postulate that bisphosphonates may have paradoxically increased fracture risk in our patient. ",

keywords = "genetic implications, clinical implications, clinical and genetic implications, Autosomal dominant hypocalcaemia, novel CASR mutation",

author = "Lucia Gagliardi and Burt, {Morton G.} and Jinghua Feng and Poplawski, {Nicola K.} and Scott, {Hamish S.}",

year = "2016",

month = sep,

doi = "10.1111/cen.13104",

language = "English",

volume = "85",

pages = "495--497",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Autosomal dominant hypocalcaemia due to a novel CASR mutation

T2 - clinical and genetic implications

AU - Gagliardi, Lucia

AU - Burt, Morton G.

AU - Feng, Jinghua

AU - Poplawski, Nicola K.

AU - Scott, Hamish S.

PY - 2016/9

Y1 - 2016/9

N2 - We report a patient from a family with autosomal dominant hypocalcaemia who also had prednisolone‐treated Langerhans’ cell histiocytosis and familial genetic studies identifying a novel calcium‐sensing receptor (CASR ) mutation. We describe an approach to define pathogenicity of a genetic variation of uncertain significance and postulate that bisphosphonates may have paradoxically increased fracture risk in our patient.

AB - We report a patient from a family with autosomal dominant hypocalcaemia who also had prednisolone‐treated Langerhans’ cell histiocytosis and familial genetic studies identifying a novel calcium‐sensing receptor (CASR ) mutation. We describe an approach to define pathogenicity of a genetic variation of uncertain significance and postulate that bisphosphonates may have paradoxically increased fracture risk in our patient.

KW - genetic implications

KW - clinical implications

KW - clinical and genetic implications

KW - Autosomal dominant hypocalcaemia

KW - novel CASR mutation

UR - http://www.scopus.com/inward/record.url?scp=84982084105&partnerID=8YFLogxK

UR - http://purl.org/au-research/grants/NHMRC/1023059

U2 - 10.1111/cen.13104

DO - 10.1111/cen.13104

M3 - Letter

C2 - 27177819

AN - SCOPUS:84982084105

SN - 0300-0664

VL - 85

SP - 495

EP - 497

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 3

ER -

Autosomal dominant hypocalcaemia due to a novel CASR mutation: clinical and genetic implications

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this